文献速递消化系统肿瘤

单细胞测序揭示胰腺癌肿瘤浸润淋巴细胞状态的演化轨迹

Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.
PubMed 文献 · Cancer Discov · 2022-01-01

研究对57例胰腺导管腺癌(PDAC)样本、22例未受累/正常样本及培养的肿瘤浸润淋巴细胞(TIL)共8万个T细胞进行单细胞转录组和T细胞受体分析,定义了20种细胞状态并揭示TIL群体异质性分布。CD8+ TIL中存在基于TCR克隆型共享的过渡性GZMK+群体,其状态轨迹与GZMB+PRF1+细胞毒性群体及CXCL13+功能障碍群体相似。统计分析提示某些TIL状态(如功能障碍和抑制性群体)常同时出现,培养TIL中效应群体的高频克隆优先扩增。

要点

  • PDAC的TIL landscape包含20种细胞状态,群体分布高度异质。
  • CD8+ TIL中GZMK+过渡群体与细胞毒性及功能障碍状态轨迹相似。
  • 功能障碍和抑制性TIL状态常同时出现,效应群体高频克隆优先扩增。

核心结论

  • 研究提供了PDAC TIL亚群及其关系的参考图谱,为未来PDAC免疫治疗中TIL的应用奠定基础。

研究设计与样本

  • 研究对57例PDAC样本、22例未受累/正常样本及培养的TIL共8万个T细胞进行单细胞转录组和T细胞受体分析。

主要发现

  • 数据揭示20种细胞状态和TIL群体的异质性分布。
  • CD8+ TIL包含基于TCR克隆型共享的推定过渡性GZMK+群体。
  • 细胞状态轨迹分析显示GZMK+群体与GZMB+PRF1+细胞毒性群体及CXCL13+功能障碍群体相似。
  • 统计分析提示某些TIL状态(如功能障碍和抑制性群体)常同时出现。
  • 培养TIL分析显示效应群体的高频克隆优先扩增。

关键数值与推荐

  • 共分析8万个T细胞,来自57例PDAC样本、22例未受累/正常样本及培养的TIL。
  • 定义20种细胞状态。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Pancreatic ductal adenocarcinoma (PDAC) has few effective treatments. Immunotherapy, an attractive alternative strategy, remains challenging with the lack of knowledge on the tumor-infiltrating lymphocyte (TIL) landscape in PDAC. To generate a reference of T-cell subpopulations, we profiled 80,000 T cells from 57 PDAC samples, 22 uninvolved/normal samples, and cultured TIL using single-cell transcriptomic and T-cell receptor analysis. These data revealed 20 cell states and heterogeneous distributions of TIL populations. The CD8+ TIL contained a putative transitional GZMK+ population based on T-cell receptor clonotype sharing, and cell-state trajectory analysis showed similarity to a GZMB+PRF1+ cytotoxic and a CXCL13+ dysfunctional population. Statistical analysis suggested that certain TIL states, such as dysfunctional and inhibitory populations, often occurred together. Finally, analysis of cultured TIL revealed that high-frequency clones from effector populations were preferentially expanded. These data provide a framework for understanding the PDAC TIL landscape for future TIL use in immunotherapy for PDAC. SIGNIFICANCE: To improve the efficacy of immunotherapy in PDAC, there is a great need to understand the PDAC TIL landscape. This study represents a reference of PDAC TIL subpopulations and their relationships and provides a foundation upon which to base future immunotherapeutic efforts. This article is highlighted in the In This Issue feature, p. 2221.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Schalck A, Sakellariou-Thompson D, Forget MA, et al. Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer. Cancer Discov. 2022. PMID: 35849783. doi:10.1158/2159-8290.CD-21-1248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。